Single-Cell Analysis Uncovers Regulatory Program in Rare Leukemia

Dec

Non-Invasive Characterization of Solid Tumors via NGS Liquid Biopsy Testing

This webinar will review how liquid biopsy can be considered as an alternative and non-invasive method to tissue biopsy for cancer molecular characterization.

Dec

Featured Webinar

Evolution of Tumor Profiling in a Clinical Lab: Moving toward Comprehensive Genomic Profiling

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.

Jan

Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Menu

Single-Cell Analysis Uncovers Regulatory Program in Rare Leukemia

To read the full story....

Breaking News

GenMark Diagnostics Downgraded by JP Morgan to Neutral

Twist Bioscience Fiscal Q4 Revenues Increase 87 Percent

Parkinson's Foundation Selects Five Sites for Genetic Testing, Counseling

Oxford BioDynamics Fiscal 2019 Revenues Down 24 Percent

At ASH, Researchers Discuss Rapid AML Nanopore Sequencing Assay for Analyzing Actionable Alterations

Enzo Biochem Fiscal Q1 Revenues Down 5 Percent

Recent Headlines from
Precision Oncology News

Classification Algorithm Divides Pancreatic Cancer Patients by Likely Treatment Response, Outcome

Oncologists, Patient Groups Eagerly Await Access to KRAS Inhibitors Based on Promising Early Data

Oncolytic Viruses May Help Cancer Patients Overcome Resistance to Immunotherapy, Research Shows

Mayo Clinic Researchers Plan to Launch Trials for Preventative Breast Cancer Vaccine in 2020

Q&A: The Parker Institute's Theresa LaVallee on the Path Forward for Precision Immuno-Oncology

Featured White Papers

Non-Invasive Characterization of Solid Tumors via NGS Liquid Biopsy Testing

Evolution of Tumor Profiling in a Clinical Lab: Moving toward Comprehensive Genomic Profiling

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

What's Popular?

At ASH, Researchers Discuss Rapid AML Nanopore Sequencing Assay for Analyzing Actionable Alterations

Colorado Center for Personalized Medicine Biobank Begins Returning Participant PGx Results

Roche Ending Partnership With Syapse

ASH Study Points to Distinct AML, MDS Subtypes Based on Genomic, Transcriptomic Analysis

Array Genomics Sets Out to Build Business for Bladder Cancer Test

Sponsorships